lncRNA XIST could be used to select triple-negative breast cancer patients for ERbeta therapy Dec. 10, 2021
Mdm2 gene amplification is associated with poor outcome of patients with luminal breast cancer Dec. 10, 2021
HDAC6 linked to higher risk of relapse in HER2-positive breast cancer treated with trastuzumab Dec. 10, 2021
Plexin D1-positive extracellular vesicles as potential biomarker of polymyositis and dermatomyositis Nov. 17, 2021
RSS